{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:43Z","timestamp":1788355363626,"version":"build-2803163510"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Individuals with HIV are at increased risk for ESKD. Kidney transplantation is the best treatment for ESKD in the HIV+ population. Despite reduced access to transplantation, patients who are HIV+ have excellent outcomes and clearly benefit from receiving one. Common post-transplant complications and management concerns, including the optimal antiretroviral regimen, immunosuppression protocols, infectious prophylaxis, hepatitis C coinfection, metabolic complications, and malignancy are all discussed.<\/jats:p>","DOI":"10.34067\/kid.0002112020","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T22:05:15Z","timestamp":1588802715000},"page":"705-711","source":"Crossref","is-referenced-by-count":11,"title":["Kidney Transplantation in Patients with HIV"],"prefix":"10.34067","volume":"1","author":[{"given":"Deirdre","family":"Sawinski","sequence":"first","affiliation":[{"name":"Renal, Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"B1-20230821","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciu919","article-title":"End-stage renal disease among HIV-infected adults in North America","volume":"60","author":"Abraham","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B2-20230821","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000019773.43765.BF","article-title":"Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States","volume":"13","author":"Ahuja","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B3-20230821","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.kint.2017.08.015","article-title":"Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice","volume":"93","author":"Sawinski","year":"2018","journal-title":"Kidney Int"},{"key":"B4-20230821","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1600-6143.2009.02637.x","article-title":"Factors associated with failure to list HIV-positive kidney transplant candidates","volume":"9","author":"Sawinski","year":"2009","journal-title":"Am J Transplant"},{"key":"B5-20230821","doi-asserted-by":"crossref","first-page":"e12777","DOI":"10.1111\/tid.12777","article-title":"Barriers to listing for HIV-infected patients being evaluated for kidney transplantation","volume":"19","author":"Lee","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"B6-20230821","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa1001197","article-title":"Outcomes of kidney transplantation in HIV-infected recipients [published correction appears in N Engl J Med 364: 1082, 2011]","volume":"363","author":"Stock","year":"2010","journal-title":"N Engl J Med"},{"key":"B7-20230821","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2215\/CJN.07460716","article-title":"Access to kidney transplantation among HIV-infected waitlist candidates","volume":"12","author":"Locke","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20230821","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1111\/ajt.15500","article-title":"Access to the waiting list and to kidney transplantation for people living with HIV: a national registry study","volume":"19","author":"Tourret","year":"2019","journal-title":"Am J Transplant"},{"key":"B9-20230821","doi-asserted-by":"crossref","first-page":"e13466","DOI":"10.1111\/ctr.13466","article-title":"Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus","volume":"33","author":"Cohen","year":"2019","journal-title":"Clin Transplant"},{"key":"B10-20230821","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/SLA.0000000000001761","article-title":"Survival benefit of kidney transplantation in HIV-infected patients","volume":"265","author":"Locke","year":"2017","journal-title":"Ann Surg"},{"key":"B11-20230821","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ki.2015.74","article-title":"Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV\/HCV-coinfected recipients","volume":"88","author":"Sawinski","year":"2015","journal-title":"Kidney Int"},{"key":"B12-20230821","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1681\/ASN.2014070726","article-title":"A national study of outcomes among HIV-infected kidney transplant recipients","volume":"26","author":"Locke","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230821","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/ajt.13080","article-title":"Effect of HCV\/HIV coinfection versus HCV monoinfection in kidney transplant recipients","volume":"15","author":"Kayler","year":"2015","journal-title":"Am J Transplant"},{"key":"B14-20230821","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc1903013","article-title":"Longer-term outcomes of HIV-positive-to-HIV-positive renal transplantation","volume":"381","author":"Selhorst","year":"2019","journal-title":"N Engl J Med"},{"key":"B15-20230821","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2011.03506.x","article-title":"Estimating the potential pool of HIV-infected deceased organ donors in the United States","volume":"11","author":"Boyarsky","year":"2011","journal-title":"Am J Transplant"},{"key":"B16-20230821","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/ajt.13308","article-title":"An assessment of HIV-infected patients dying in care for deceased organ donation in a United States urban center","volume":"15","author":"Richterman","year":"2015","journal-title":"Am J Transplant"},{"key":"B17-20230821","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.15681","article-title":"Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results","volume":"20","author":"Durand","year":"2020","journal-title":"Am J Transplant"},{"key":"B19-20230821","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/ajt.14235","article-title":"Risk of end-stage renal disease in HIV-positive potential live kidney donors","volume":"17","author":"Muzaale","year":"2017","journal-title":"Am J Transplant"},{"key":"B20-20230821","doi-asserted-by":"crossref","first-page":"e13499","DOI":"10.1111\/ctr.13499","article-title":"Solid organ transplantation in the HIV-infected patient: Guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Blumberg","year":"2019","journal-title":"Clin Transplant"},{"key":"B21-20230821","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1600-6143.2007.02007.x","article-title":"Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients","volume":"7","author":"Frassetto","year":"2007","journal-title":"Am J Transplant"},{"key":"B22-20230821","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/apc.2012.0169","article-title":"Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a review","volume":"26","author":"van Maarseveen","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"B23-20230821","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.14419","article-title":"Impact of protease inhibitor-based anti-retroviral therapy on outcomes for HIV+ kidney transplant recipients","volume":"17","author":"Sawinski","year":"2017","journal-title":"Am J Transplant"},{"key":"B24-20230821","doi-asserted-by":"crossref","first-page":"e12727","DOI":"10.1111\/tid.12727","article-title":"Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients","volume":"19","author":"Boyle","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"B25-20230821","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/ajt.14895","article-title":"The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"key":"B26-20230821","doi-asserted-by":"crossref","first-page":"e13532","DOI":"10.1111\/ctr.13532","article-title":"Clinical outcomes in HIV+\/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-year single center experience","volume":"33","author":"Camargo","year":"2019","journal-title":"Clin Transplant"},{"key":"B27-20230821","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/ajt.15239","article-title":"Optimal timing of hepatitis C treatment among HIV\/HCV coinfected ESRD patients: Pre- vs posttransplant","volume":"19","author":"Shelton","year":"2019","journal-title":"Am J Transplant"},{"key":"B28-20230821","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/ajt.13985","article-title":"Association between duration of human immunodeficiency virus (HIV)-1 viral suppression prior to renal transplantation and acute cellular rejection","volume":"17","author":"Husson","year":"2017","journal-title":"Am J Transplant"},{"key":"B29-20230821","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.TP.0000436905.54640.8c","article-title":"Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients","volume":"97","author":"Locke","year":"2014","journal-title":"Transplantation"},{"key":"B30-20230821","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/ajt.13840","article-title":"Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus","volume":"16","author":"Kucirka","year":"2016","journal-title":"Am J Transplant"},{"key":"B31-20230821","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/TP.0000000000000879","article-title":"Impact of tacrolimus compared with cyclosporin on the incidence of acute allograft rejection in human immunodeficiency virus-positive kidney transplant recipients","volume":"100","author":"Gathogo","year":"2016","journal-title":"Transplantation"},{"key":"B32-20230821","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/ajt.12699","article-title":"Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients","volume":"14","author":"Stock","year":"2014","journal-title":"Am J Transplant"},{"key":"B33-20230821","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/tri.12377","article-title":"Kidney transplantation in HIV-positive patients treated with a steroid-free immunosuppressive regimen","volume":"27","author":"Bossini","year":"2014","journal-title":"Transpl Int"},{"key":"B34-20230821","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2018.02.352","article-title":"Kidney transplantation in HIV-positive patients: a single-center, 16-year experience","volume":"73","author":"Malat","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"B35-20230821","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/tri.12249","article-title":"Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation","volume":"27","author":"Longuet","year":"2014","journal-title":"Transpl Int"},{"key":"B36-20230821","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/ajt.13782","article-title":"Pretransplant CD4 count influences immune reconstitution and risk of infectious complications in human immunodeficiency virus-infected kidney allograft recipients","volume":"16","author":"Suarez","year":"2016","journal-title":"Am J Transplant"},{"key":"B37-20230821","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"B38-20230821","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"B39-20230821","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines [published correction appears in J Am Coll Cardiol 71: e136\u2013e139, 2018]","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B40-20230821","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11892-018-1076-3","article-title":"Diabetes and HIV","volume":"18","author":"Noubissi","year":"2018","journal-title":"Curr Diab Rep"},{"key":"B41-20230821","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"B42-20230821","first-page":"CD005019","article-title":"HMG CoA reductase inhibitors (statins) for kidney transplant recipients","volume":"28","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B43-20230821","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-018-3162-1","article-title":"Statin use and all-cause mortality in people living with HIV: A systematic review and meta-analysis","volume":"18","author":"Uthman","year":"2018","journal-title":"BMC Infect Dis"},{"key":"B44-20230821","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"B45-20230821","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"B46-20230821","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: A collaboration of cohort studies [published correction appears in Lancet HIV 6: e815, 2019]","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"key":"B47-20230821","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"B48-20230821","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fmed.2018.00211","article-title":"Mineral and bone disorders after kidney transplantation","volume":"5","author":"Vangala","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B49-20230821","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B50-20230821","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0002112020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:56:54Z","timestamp":1786478214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0002112020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0002112020","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}